NCT07426484 2026-02-23Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic MalignancyDana-Farber Cancer InstitutePhase 4 Not yet recruiting80 enrolled
NCT04305145 2026-01-29Infliximab for Treatment of Immune Checkpoint Inhibitor ColitisMassachusetts General HospitalPhase 2 Active not recruiting42 enrolled